Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naive or Switching Patients: A Systematic Review

Ebbers, HC; Pieper, B; Issa, A; Addison, J; Freudensprung, U; Rezk, MF

Ebbers, HC (reprint author), Biogen Int GmbH, Baar, Switzerland.

RHEUMATOLOGY AND THERAPY, 2019; 6 (3): 317

Abstract

Introduction In 2016, SB4 (Benepali (R)) became the first etanercept (ETN) biosimilar to obtain marketing authorisation in Europe. Despite robust anal......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索